JOHANNESBURG, 29 November 2013 (IRIN) - The world's largest antiretroviral (ARV) programme is in crisis. One in five health facilities in South Africa reported a stock-out of antiretroviral (ARV) or tuberculosis (TB) medication in the past three months, putting the lives of many patients in jeopardy, according to activists.
The stakes are dangerously high: over 2.4 million people are receiving ARVs at public sector facilities, while the TB programme treats over 300,000 people every year...
This story is part of New Europe's Premium content.
|To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑|